The dimorphic fungus Histoplasma capsulatum exists in two phases: as a unicellular yeast at 37 C and a multicellular mycelia at 25 C (5). We have found differences in amphotericin B (AmB) and actinomycin D (ActD) susceptibilities between these two phases. These differences in susceptibility occurred early in the transition between the two and permitted the temperaturerelated transition from one phase to the other to be blocked by sublethal concentrations of the drugs.
MATERIALS AND METHODS
Antibiotics and radioactive material. AmB in the form of Fungizone (E.R. Squibb & Sons, Inc., Princeton, N. J.) was dissolved and diluted in distilled water. ActD (Sigma Chemical Co., St. Louis, Mo.) was prepared as an aqueous stock solution (0.5 mg/ml) and stored at -20 C until used. ["C ]guanine (8- (15) and incubating at room temperature (24 to 26 C) for 2 weeks.
Drug susceptibility assays. Yeast cells from a 3-to 5-day-old plate were suspended in Salvin's medium at a cell number of 2 x 106 cells/ml and incubated without shaking for 24 to 36 h. The cell number was then readjusted to 2 x 106 cells/ml just before the susceptibility assays were performed.
Mycelia were maintained in homogeneous suspension in submerged cultures in Salvin's medium. They were transferred to fresh medium 2 to 3 days before the assay of antibiotic susceptibility. Density of the actively growing mycelia was adjusted with fresh medium so that an equal volume of suspension would give a similar cell mass in dry weight as the yeast cells being tested (dry weight mycelia equal to 2 x 106 yeast cells/ml).
AmB or ActD was added to the assay medium at the concentrations described and the ["C]guanine was added 1 h later at a concentration of 0.1 ACi of medium per ml. One-milliliter samples were taken at 1-,3-, and 6-h intervals. They were precipitated with an equal volume of cold 10% trichloroacetic acid (CClCOOH) and were filtered, dried, and counted on a scintillation counter.
Dry weights of the two forms after 3 days of growth in the presence of AmB were measured by mixing 30 to 50 ml of cells with 50% CCl3COOH to a final concentration of 5%. The cells were collected on preweighed glass fiber filters. The samples were dried in a 150 C oven for 2 h, cooled for 1 h, and weighed on a Metler H20T balance. The total weight minus the weight of the filter paper was defined as the dry weight of the organism. Total ribonucleic acid (RNA) was determined by a modification of the SchmidtThannhauser procedure described elsewhere (1, 6 temperature for 24 h, they displayed an AmB dose response pattern similar to that of the mycelial form, although at this time only very small germ tubes were evident (Fig. 1) . When the cultures were pulse labeled for 3 h with ["CC]guanine, it could be seen that the change in AmB susceptibility of the yeast actually occurred within 4 h after the temperature shift, before any germ tubes were evident (Fig. 2) . Figure 2A shows the marked susceptibility of mycelia to 0.005 ,ug of AmB per ml. Inhibition of RNA synthesis occurred immediately after the addition of AmB. Figure 2B shows the gradual switch to sensitivity to 0.005 ,Ci of AmB per ml after the yeast was changed to an incubation temperature of 25 C. At 4 h the total ["C ]guanine incorporated into RNA was less than 20% of the control cells. Figure 2C shows that the insusceptibility of yeast to 0.005 tig of AmB per ml did not change after the 4 h of incubation at 37 C.
Both forms of H. capsulatum were susceptible to ActD, but the yeast form was slightly more susceptible than the mycelial form, as measured by ["C ]guanine incorporation (Fig.   3) . The difference in susceptibility to ActD between the yeast and mycelial forms was more striking when the cells were first incubated with the drug for 3 days and then subcultured on fresh GYE plates (Fig. 4A-C) . A 50-,Mg/ml amount of ActD did not visibly affect subcultures of mycelia (Fig. 4A) with ActD. At 7 days clusters of yeast cells were seen among the mycelial masses without ActD (Fig. 6A) . In the cells incubated for 7 days with 10 ,ug of ActD per ml, only occasional hyphal tip constrictions were seen, but no unicellular yeast could be found (Fig. 6B) . Most of the hyphal tips examined were filled with cytoplasm, indicating that all the cells were still viable. In the cells incubated with 25 ,g of ActD per ml, slightly constricted and swollen hyphae were observed, and 50% of the hyphae were vacuolated (Fig. 6C) . In the cells incubated with 50 /tg of ActD per ml, all but a few hyphae were vacuolated and empty (Fig. 6D) . Nevertheless, subcultures of these mycelia, even after incubation with ActD for 7 days, were viable and grew out as yeast at 37 C and as mycelia at 25 C. DISCUSSION Phase transitions in microorganisms, particularly in sporulating Bacillus subtilis, can be arrested at specific stages by appropriate mutational lesions, and spores traditionally can be classified into several stages by changes in the envelope that lead to progressive resistance to several substances (chloroform, octanol, etc.) (17) .
The case of H. capsulatum described here is analogous in that differential drug susceptibilities exist for the cells in different growth states; however, here the transition is from one growing state to another, rather than from a growing cell to a storage form. Very likely many other growth phase-specific inhibitors exist, perhaps with even greater selectivity.
The inhibition of the transition by AmB and ActD probably does not occur by nonspecific killing. If that alternative were true, all of the cells eventually would have been killed by these agents. Since AmB was fungistatic for as long as 12 days after the Y-aM shift began, and the ActD-inhibited M-IY transition produced little killing even at 7 days, this mechanism is not likely.
The observation that delay of addition of AmB for 4 h after the temperature shift eliminated the inhibition of the transition argues that a critical event occurs within this 4-h period, and the AmB has to be added within this time period to achieve its effect. The subsequent cell death in the yeast incubated in AmB at 25 C would probably then be a secondary effect.
The mechanism by which AmB and ActD arrested the Y-M and M-Y transition is unknown. AmB likely caused leakage of essential elements from the cell (2-4, 11) . However, it might act by a very different mechanism; for example, it might have prevented early changes in the cell envelope essential for the transition by binding to the cell membrane (9) (10) (11) (12) (13) 16 (8) . Yeast cells would then be more permeable to ActD than mycelia, and therefore more susceptible.
The time in the Y-M transition when the yeast cells assumed the mycelia,l susceptibility to AmB, 4 h after transfer to 25 C, is consistent with the notion of a change in the cell envelope. At about that time, electron microscopic observations have shown an involuted membrane system at a region near the cell wall (7) . The data are also consistent with observations on Aspergillus fumigatus, for which a 15-fold increase in AmB methyl ester susceptibility occurred during the early stage of conidial germination, before appearance of germ tubes (14) .
The arrested transition produced by the differential susceptibility of the yeast and mycelial forms to AmB and ActD may be useful in elucidating features of morphogenesis. For example, the arrested transition produced by the differential susceptibility of the yeast and mycelial forms might aid in selection of nontransforming mutants or synchronization of cultures. Initial trials with yeast incubated at 25 C in the presence of AmB for 1 to 3 days and then washed free of antibiotic have shown yeast germinating uniformly, with good synchrony (unpublished data).
